Abstract 4347: Preclinical evaluation of pharmacokinetic interactions among nebivolol, dasatinib and devimistat in miceAirong Li, Amir Mohammad Gholizadeh, Emanuel Baltrip et al.|Cancer Research|2025Cited by 1
Abstract 515: Repurposing nebivolol with dasatinib and CPI-613: A synergistic strategy to combat triple-negative breast cancerMikayla Skillman, Meghana V. Trivedi, Airong Li et al.|Cancer Research|2025Cited by 0